All Andrew Dillon articles
See all articles with this subject.
-
News‘Suboptimal’ relationship between NHS and pharma needs ‘urgent’ attention, says ex-NICE chief
The relationship between the NHS and the pharmaceutical sector is ‘suboptimal’ because of the misalignment of ‘ambitions, constraints and risk appetites’, according to former National Institute for Health and Care Excellence Sir Andrew Dillon.
-
NewsAndrew Dillon to end his 20 year reign at NICE
Sir Andrew Dillon will step down as the chief executive of the National Institute for Health and Care Excellence in March 2020 after more than 20 years in the role.
-
CommentDillon: We should have thought harder on safe staffing
This week: Sir Andrew Dillon, chief executive of the National Institute for Health and Care Excellence
-
-
NewsNICE chief: NHS faces 'startling costs' from new treatments
NICE chief executive said NHS faces “startling new costs” from new medical technologies Sir Andrew Dillon says system will have to confront new payment models for high cost drugs Reveals new cross-body panel now looks at potential impact of new drugs The NHS faces a “material challenge” to ...
-
NewsSafe staffing leak: How we got here
HSJ has today published the final safe nurse staffing guidance for accident and emergency departments produced by NICE. We have covered this important story since the beginning. Here we recap the main events to get you up to speed.
-
NewsDirectors to review NICE chief's decision not to release staffing guidance
Non-executive directors to review NICE chief’s decision not to release safe staffing work Sir Andrew Dillon claimed publishing evidence reviews of safe nurse staffing could disrupt management of the health service Decision not to publish followed freedom of information request by HSJ Two non-executive directors at the National ...
-
NewsExclusive: NICE safe staffing U-turn followed meeting with Hunt's office
A decision by NICE to reverse its plans to publish work on safe nurse staffing levels came immediately after an email exchange between its chief executive and Jeremy Hunt’s office, HSJ can reveal.
-
NewsNICE makes U-turn over publishing safe staffing guidance
Plans to publish safe nurse staffing guidance for emergency departments have been abandoned in a U-turn by the National Institute for Health and Care Excellence.
-
NewsNHS England director: 'Budget constraint' to blame for hepatitis C drug delays
Delays to the introduction of groundbreaking, cost effective hepatitis C drugs have occurred because of ‘budget constraint’, NHS England’s specialised commissioning director has indicated.
-
NewsNICE on the offensive in row over breast cancer drug
NICE has taken the unprecedented step of expressing its ‘disappointment’ with a multinational drug giant in a row over a new breast cancer drug and the government’s pricing deal
-
NewsNICE chief: Approval changes 'won't increase NHS drugs bill'
The head of the National Institute of Health and Care Excellence has suggested the NHS will not pay more overall for branded pharmaceuticals in future as a result of proposed changes to the way the organisation assesses the value of new drugs.
-
NewsNICE chief demands transparency over trial data
The National Institute for Health and Care Excellence chief executive has said that the pharmaceutical industry should disclose more data from clinical trials.
-
CommentSometimes the NHS needs a sensible spot of panic
We need to kick up a fuss over old problems
-
NewsClinical assessment service joins litigation authority
The body that deals with concerns over the professional practice of doctors, pharmacists and dentists is to become an operating division of the NHS Litigation Authority.
-
NewsValue-based pricing 'will not improve' cancer drug access
Government proposals to introduce a value-based pricing system for new drugs will not significantly improve patient access to treatments, experts have warned.
-
News
NICE guidance on cost-saving drug not sought by DH
The Department of Health failed to act on expert advice to commission an appraisal of a drug which could lead to savings of £100m for the NHS, it has emerged.
-
Comment
HSJ100: Top 5 'inquirers' and regulators
This year’s Top 5 ‘inquirers’ and regulators in the HSJ100.
-
Information009 - Sir Andrew Dillon
Chief executive, National Institute for Health and Clinical Excellence (2010 ranking: 17)
-
LeaderMake an ‘impossible job’ easier by following a NICE example
“I don’t mind people thinking I’m incompetent, although I don’t want them to,” Care Quality Commission chief executive Cynthia Bower told HSJ this week.